Back to Top Skip to main content Skip to sub-navigation

COVID-19 vaccine does not affect fertility, immunization experts say

Black and white photo of a couple holding hands An Army couple holds hands while listening to a counselor explore reasons why the woman should or should not receive a COVID-19 vaccination while pregnant. Ultimately, those eligible for the immunizations must make their own choices about getting vaccinated while pregnant or choose to wait until after birth to get vaccinated. The same decision extends to people who are breastfeeding. (Photo by Army Sgt. Maricris C. McLane.)

Recommended Content:

Women's Health | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

You’re pregnant, or you’re breastfeeding. Should you get a COVID-19 vaccine?

That’s a question on the minds of many military frontline health care workers today. The short answer is that it’s an individual’s choice, and military health experts say the vaccine is well worth considering.

As the COVID-19 vaccines continue to be administered across military hospitals and smaller clinics and outposts under Centers for Disease Control and Prevention guidance, the advice from the military and a multitude of national maternal and fetal health professional associations is the same: For most pregnant people, getting the COVID-19 vaccine as soon as possible is the safest choice based on the science to date.

The COVID-19 vaccines made by Pfizer and Moderna are mRNA vaccines. These vaccines contain no live viruses that could directly infect a mother or baby.

“As of Jan. 21, more than 15,000 pregnant patients had received an mRNA vaccine,” said retired Navy Capt. (Dr.) Margaret Ryan, medical director, Defense Health Agency Immunization Division, Pacific Region Vaccine Safety Hub, San Diego. “The experiences of these pregnancies are being followed very closely, and no specific safety concerns have been reported so far.

“As COVID-19 vaccines were being developed, studies in the laboratory and animals showed no reproductive health problems,” Ryan added.

Pregnant people are entering clinical trials for COVID-19 vaccines “literally now and going into March, so more data will be known soon,” Dr. Anthony Fauci, President Joe Biden’s chief medical adviser on COVID-19, told a Blue Star Families virtual town hall Feb. 4.

Of the 15,000 pregnant people who have received at least one of the 32 million vaccinations in the United States, “there have been no red flags of adverse events. Many who are pregnant are health care providers who said the risk of getting COVID-19 from their patients was worse than that from getting the vaccine,” said Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.

Said Ryan: “Although it is unclear how pregnancy may affect infection risk, some women who have been infected with COVID-19 during pregnancy have experienced serious illness or death. COVID-19 infection in pregnancy also seems to increase risk of preterm birth.”

As for those who do not want to take the vaccine, “we know there are significantly increased risks for pregnant people who contract COVID-19, e.g., they are three times more likely to be admitted to the ICU and need breathing support,” said Navy Cmdr. (Dr.) Monica Lutgendorf, division head Maternal Fetal Medicine, Naval Medical Center-San Diego (NMCSD), and chair, DHA Women and Infants Clinical Community. “People with comorbidities such as diabetes, Latinx, and Black people are also more at risk for COVID-19 and death. Therefore, it is often beneficial to get the vaccine, especially for pregnant or nursing individuals at increased risk of severe disease.”

Lutgendorf noted that although relative risks of COVID-19 are increased in pregnancy, this information should be provided in the context of overall low absolute risks for breathing support (2.9 per 1,000), heart and lung support (0.7 per 1,000), and death (1.5 per 1,000).

Ryan went on to say that specialists from the CDC, American College of Obstetrics and Gynecology, and American Academy of Breastfeeding Medicine “all agree that breastfeeding should not be a barrier to receipt of a COVID-19 vaccine. Breastfeeding should never be equated to pregnancy in terms of health considerations for mother or child.”

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA PI 6200.02: Comprehensive Contraceptive Counseling and Access to the Full Range of Methods of Contraception

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), in accordance with the requirements of References (c) through (i), and the guidance of References (j) through (v), establishes the Defense Health Agency’s (DHA) procedures for comprehensive standards on healthcare with respect to access to comprehensive contraceptive counseling and the full range of contraceptive methods for members of the Armed Forces and all eligible beneficiaries of the Military Health System (MHS).

  • Identification #: 6200.02
  • Date: 5/13/2019
  • Type: DHA Procedural Instruction
  • Topics: Women's Health

Interim Guidance for Prevention of Sexual Transmission of Zika Virus

Policy

With this update, CDC is expanding its existing recommendations to cover all pregnant couples, which includes pregnant women with female sex partners. This guidance also describes what other couples (those who are not pregnant or planning to become pregnant) can do to reduce the risk for Zika virus transmission. CDC’s recommendations for couples planning to become pregnant have been published separately (9).

Showing results 1 - 12 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.